Literature DB >> 12437985

Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules.

Haiyan Song1, Nobuhiro Shojima, Hideyuki Sakoda, Takehide Ogihara, Midori Fujishiro, Hideki Katagiri, Motonobu Anai, Yukiko Onishi, Hiraku Ono, Kouichi Inukai, Yasushi Fukushima, Masatoshi Kikuchi, Hitoshi Shimano, Nobuhiro Yamada, Yoshitomo Oka, Tomoichiro Asano.   

Abstract

Expression of the adipocyte-derived protein resistin, which is thought to play a key role in the development of insulin resistance in vivo, is regulated by a variety of hormones and mediators, including insulin and TNFalpha. Here we describe our use of adenovirus-mediated gene transfer to determine which transcription factors and signaling pathways affect resistin expression in 3T3-L1 adipocytes. We found that resistin expression was enhanced by overexpression of C/EBPalpha and suppressed by C/EBPzeta, a negative regulator of C/EBPalpha. Additionally, C/EBPalpha induced resistin even in L6 myocytes. Overexpression of PPARgamma markedly reduced resistin expression, whereas PPARalpha had no significant effect. Resistin expression was markedly suppressed by overexpression of the PI3-kinase p110alpha catalytic subunit and by Akt. Finally, overexpression of MEK1, MKK6, or MKK7 suppressed resistin expression. These findings indicate that resistin expression is regulated by C/EBPalpha and PPARgamma, partly via modulation of signal transduction in the PI3-kinase and MAP kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437985     DOI: 10.1016/s0006-291x(02)02551-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The physiological role of resistin and its connection with metabolic diseases.

Authors:  K Motojima
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 2.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

3.  Effect of tumor necrosis factor-alpha on resistin expression in 3T3-L1 adipocytes and its mechanism.

Authors:  Zaigang Yang; Muxun Zhang; Lijun Xu; Jianhua Zhang; Wang Hongwei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.

Authors:  C Otto; B Otto; B Göke; A F H Pfeiffer; M Lehrke; M Vogeser; J Spranger; K G Parhofer
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 5.  Immune regulation of metabolic homeostasis in health and disease.

Authors:  Jonathan R Brestoff; David Artis
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

Review 6.  Resistin: molecular history and prognosis.

Authors:  Ronadip R Banerjee; Mitchell A Lazar
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

7.  Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.

Authors:  Christine Kurlawalla-Martinez; Bangyan Stiles; Ying Wang; Sherin U Devaskar; Barbara B Kahn; Hong Wu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Role of resistin in diet-induced hepatic insulin resistance.

Authors:  Evan D Muse; Silvana Obici; Sanjay Bhanot; Brett P Monia; Robert A McKay; Michael W Rajala; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma).

Authors:  Anil K Singh; Aruna Battu; Krishnaveni Mohareer; Seyed E Hasnain; Nasreen Z Ehtesham
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

Review 10.  Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.

Authors:  X Huang; Z Yang
Journal:  J Endocrinol Invest       Date:  2015-12-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.